Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
Y Wu, W Zhu, X He, R Xue, W Liang, F Wei… - British Journal of …, 2021 - bjgp.org
Background Polypharmacy is common in heart failure (HF), whereas its effect on adverse
outcomes in patients with HF with preserved ejection fraction (HFpEF) is unclear. Aim To …
outcomes in patients with HF with preserved ejection fraction (HFpEF) is unclear. Aim To …
Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial.
Y Wu, W Zhu, X He, R Xue, W Liang, F Wei… - The British Journal of …, 2020 - europepmc.org
Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a
retrospective analysis on adverse outcomes in the TOPCAT trial. - Abstract - Europe PMC Sign …
retrospective analysis on adverse outcomes in the TOPCAT trial. - Abstract - Europe PMC Sign …
[PDF][PDF] Influence of polypharmacy on patients with heart failure with preserved ejection fraction
Y Wu, W Zhu, X He, R Xue, W Liang… - British Journal of …, 2021 - pdfs.semanticscholar.org
Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a
retrospective analysis on adverse o Page 1 Research Yuzhong Wu, Wengen Zhu, Xin He …
retrospective analysis on adverse o Page 1 Research Yuzhong Wu, Wengen Zhu, Xin He …
[PDF][PDF] Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
Y Wu, W Zhu, X He, R Xue, W Liang, F Wei… - British Journal of …, 2020 - bjgp.org
Background Polypharmacy is common in heart failure (HF), whereas its effect on adverse
outcomes in patients with HF with preserved ejection fraction (HFpEF) is unclear. Aim To …
outcomes in patients with HF with preserved ejection fraction (HFpEF) is unclear. Aim To …
Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
Y Wu, W Zhu, X He, R Xue, W Liang, F Wei, Z Wu… - 2020 - pubmed.ncbi.nlm.nih.gov
Background Polypharmacy is common in heart failure (HF), whereas its effect on adverse
outcomes in patients with HF with preserved ejection fraction (HFpEF) is unclear. Aim To …
outcomes in patients with HF with preserved ejection fraction (HFpEF) is unclear. Aim To …
Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
Y Wu, W Zhu, X He, R Xue, W Liang, F Wei… - British Journal of …, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> Polypharmacy is common in
heart failure (HF), whereas its effect on adverse outcomes in patients with HF with preserved …
heart failure (HF), whereas its effect on adverse outcomes in patients with HF with preserved …
[HTML][HTML] Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
Y Wu, W Zhu, X He, R Xue, W Liang, F Wei… - The British Journal of …, 2021 - ncbi.nlm.nih.gov
Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a
retrospective analysis on adverse outcomes in the TOPCAT trial - PMC Back to Top Skip to main …
retrospective analysis on adverse outcomes in the TOPCAT trial - PMC Back to Top Skip to main …